Compare TDAY & VIR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | TDAY | VIR |
|---|---|---|
| Founded | 2013 | 2016 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Newspapers/Magazines | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 866.5M | 1.0B |
| IPO Year | N/A | 2019 |
| Metric | TDAY | VIR |
|---|---|---|
| Price | $6.59 | $8.96 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 1 | 10 |
| Target Price | $10.00 | ★ $29.30 |
| AVG Volume (30 Days) | 1.4M | ★ 2.5M |
| Earning Date | 01-01-0001 | 05-25-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 17.49 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $68,556,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $131.58 |
| P/E Ratio | $10.06 | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $4.54 | $4.16 |
| 52 Week High | $6.36 | $10.91 |
| Indicator | TDAY | VIR |
|---|---|---|
| Relative Strength Index (RSI) | 64.63 | 62.64 |
| Support Level | $5.61 | $4.88 |
| Resistance Level | N/A | N/A |
| Average True Range (ATR) | 0.28 | 0.53 |
| MACD | 0.02 | 0.17 |
| Stochastic Oscillator | 84.14 | 51.60 |
USA Today Co Inc is a diversified media company with expansive reach at the national and local level, dedicated to empowering and enriching communities. It prioritizes a digital-first approach, focusing on audience growth and engagement while diversifying revenue streams. Through its trusted brands, including the USA TODAY NETWORK, comprised of the national publication, USA TODAY, and local media organizations, including a network of local properties, in the United States, and Newsquest, a wholly-owned subsidiary operating in the United Kingdom, provide essential journalism, local content, and digital experiences to audiences and businesses. Its digital marketing solutions brand, LocaliQ, supports small and medium-sized businesses with digital marketing products and solutions.
Vir Biotechnology Inc is an immunology company focused on combining cutting-edge technologies to treat and prevent serious infectious diseases and other serious conditions, including viral-associated diseases. Through internal development, collaborations, and acquisitions, it has four technology platforms, focused on antibodies, T cells, innate immunity, and small interfering ribonucleic acid, or siRNA. The company's pipeline consists of product candidates targeting hepatitis B, HBV, influenza A, human immunodeficiency virus, HIV, and tuberculosis, or TB. Its revenue sources are collaboration revenue, contract revenue, grant revenue, and license revenue.